Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))-
2. Cefalexin
3. Cephalexin
4. Cephalexin Dihydride
5. Cephalexin Hemihydrate
6. Cephalexin Hydrochloride
7. Cephalexin Monohydrochloride
8. Cephalexin Monohydrochloride, Monohydrate
9. Cephalexin, (6r-(6alpha,7alpha(r*)))-isomer
10. Cephalexin, (6r-(6alpha,7beta(s*)))-isomer
11. Cephalexin, (6r-(6alpha,7beta))-isomer
12. Cephalexin, Monosodium Salt
13. Cephalexin, Monosodium Salt, (6r-(6alpha,7beta))-isomer
14. Ceporexine
15. Palitrex
1. 23325-78-2
2. Cephalexin Hydrate
3. Cefalexin Monohydrate
4. Keflet
5. Cefalexin Hydrate
6. Palitrex
7. Cefanex
8. Cephalexin (monohydrate)
9. Cephalexin.h2o
10. Cefalexin.h2o
11. Cefalival
12. Cefibacter
13. Ceffanex
14. Novolexin
15. Biocef
16. Lilly 66873
17. Panixine Disperdose
18. Cephalexin Monhydrochloride
19. Obn7uds42y
20. 7-(d-alpha-amino-alpha-phenylacetamido)-3-methyl-3-cephem-4-carboxylic Acid Monohydrate
21. Chebi:3535
22. Sq 20248
23. (6r,7r)-7-((r)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Hydrate
24. (6r,7r)-7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
25. Aristosporin
26. Cefalexgobens
27. Cephalobene
28. Adcadina
29. Azabort
30. Bactopenor
31. Cefacet
32. Cefalekey
33. Domucef
34. Doriman
35. Efemida
36. Karilexina
37. Loisine
38. Losporal
39. Ly-66873
40. Maksipor
41. Medolexin
42. Prindex
43. Rilexine
44. Rogevil
45. Servicef
46. Sintolexyn
47. Theratrex
48. Viosporine
49. Zabytrex
50. Beliam
51. Noveol
52. Ambal
53. Cephalex Von Ct
54. Henina Oral
55. Keftab (tn)
56. Cefalexina Richet
57. Cefalexin Generics
58. Cefalexina Northia
59. Cusisporina-cefalox
60. (6r,7r)-7-((r)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid Monohydrate
61. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-, Hydrate (1:1), (6r,7r)-
62. Cephalexin 1-wasser
63. Cefalexin Scand Pharm
64. Panixine
65. (6r,7r)-7-{[(2r)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid--water (1/1)
66. 7beta-[(2r)-2-amino-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic Acid--water (1/1)
67. Nsc-758162
68. Unii-obn7uds42y
69. Cephalexin (usp)
70. Prestwick_750
71. Cefalexinsodium
72. Cefalexin Monohydrate 100 Microg/ml In Acetonitrile
73. Cephalexin [usan:usp]
74. Cephalexin [usan]
75. Panixine Disperdose (tn)
76. Cephalexin [vandf]
77. Cephalexin [usp-rs]
78. Schembl41911
79. Cephalexin [orange Book]
80. Chembl1200544
81. Hy-b0200b
82. Dtxsid30945995
83. Cephalexin [usp Monograph]
84. Hms1569g17
85. Hms2096g17
86. Cephalexin Monohydrate [mi]
87. Mfcd00167148
88. S5207
89. Cephalexin Monohydrate [vandf]
90. Akos016340340
91. Cefalexin Monohydrate [who-dd]
92. Ks-1134
93. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, Monohydrate (6r-(6alpha,7beta(r*)))-
94. Cefalexin Monohydrate [ep Impurity]
95. 7-(d-.alpha.-amino-.alpha.-phenylacetamido)-3-methyl-3-cephem-4-carboxylic Acid Monohydrate
96. Cefalexin Monohydrate [ep Monograph]
97. C08099
98. D00906
99. D94616
100. A851265
101. Sr-01000759406
102. Sr-01000759406-3
103. Q27106123
Molecular Weight | 365.4 g/mol |
---|---|
Molecular Formula | C16H19N3O5S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 365.10454189 g/mol |
Monoisotopic Mass | 365.10454189 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 600 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Cephalexin Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cephalexin Monohydrate manufacturer or Cephalexin Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cephalexin Monohydrate manufacturer or Cephalexin Monohydrate supplier.
PharmaCompass also assists you with knowing the Cephalexin Monohydrate API Price utilized in the formulation of products. Cephalexin Monohydrate API Price is not always fixed or binding as the Cephalexin Monohydrate Price is obtained through a variety of data sources. The Cephalexin Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prindex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prindex, including repackagers and relabelers. The FDA regulates Prindex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prindex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prindex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prindex supplier is an individual or a company that provides Prindex active pharmaceutical ingredient (API) or Prindex finished formulations upon request. The Prindex suppliers may include Prindex API manufacturers, exporters, distributors and traders.
click here to find a list of Prindex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Prindex DMF (Drug Master File) is a document detailing the whole manufacturing process of Prindex active pharmaceutical ingredient (API) in detail. Different forms of Prindex DMFs exist exist since differing nations have different regulations, such as Prindex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Prindex DMF submitted to regulatory agencies in the US is known as a USDMF. Prindex USDMF includes data on Prindex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prindex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Prindex suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Prindex Drug Master File in Japan (Prindex JDMF) empowers Prindex API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Prindex JDMF during the approval evaluation for pharmaceutical products. At the time of Prindex JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Prindex suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Prindex Drug Master File in Korea (Prindex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prindex. The MFDS reviews the Prindex KDMF as part of the drug registration process and uses the information provided in the Prindex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Prindex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prindex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Prindex suppliers with KDMF on PharmaCompass.
A Prindex CEP of the European Pharmacopoeia monograph is often referred to as a Prindex Certificate of Suitability (COS). The purpose of a Prindex CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prindex EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prindex to their clients by showing that a Prindex CEP has been issued for it. The manufacturer submits a Prindex CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prindex CEP holder for the record. Additionally, the data presented in the Prindex CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prindex DMF.
A Prindex CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prindex CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Prindex suppliers with CEP (COS) on PharmaCompass.
A Prindex written confirmation (Prindex WC) is an official document issued by a regulatory agency to a Prindex manufacturer, verifying that the manufacturing facility of a Prindex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prindex APIs or Prindex finished pharmaceutical products to another nation, regulatory agencies frequently require a Prindex WC (written confirmation) as part of the regulatory process.
click here to find a list of Prindex suppliers with Written Confirmation (WC) on PharmaCompass.
Prindex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prindex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prindex GMP manufacturer or Prindex GMP API supplier for your needs.
A Prindex CoA (Certificate of Analysis) is a formal document that attests to Prindex's compliance with Prindex specifications and serves as a tool for batch-level quality control.
Prindex CoA mostly includes findings from lab analyses of a specific batch. For each Prindex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prindex may be tested according to a variety of international standards, such as European Pharmacopoeia (Prindex EP), Prindex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prindex USP).